Cost-effectiveness analysis of goal-directed hemodynamic treatment of elderly hip fracture patients: Before clinical research starts

Anesthesiology

Volumn 117, Issue 3, 2012, Pages 519-530

  Bartha, Erzsebet ^a   Davidson, Thomas ^b   Hommel, Ami ^c   Thorngren, Karl Göran ^d   Carlsson, Per ^b   Kalman, Sigridur ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DECISION SUPPORT SYSTEM; DECISION TREE; GERIATRIC DISORDER; HEALTH CARE COST; HIP FRACTURE; POST TREATMENT SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84865587091     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3182655eb2     Document Type: Article

References (46)

1. Commonwealth Department of Health HaCS: Guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee, including submissions involving economic analyses, Canberra: Australian Government Public Service, 2002, pp 27-42
2. Health Ontario Mo: Ontario guidelines for economic analysis of pharmaceutical products, Queen's printer for Ontario, 1994, pp 2-11
3. Claxton K, Sculpher M, Drummond M: A rational framework for decision making by the National Institute For Clinical Excellence (NICE). Lancet 2002; 360:711-5
4. Langley PC: Formulary submission guidelines for Blue Cross and Blue Shield of Colorado and Nevada. Structure, application and manufacturer responsibilities. Pharmacoeconomics 1999; 16:211-24
5. Claxton KP, Sculpher MJ: Using value of information analysis to prioritise health research: Some lessons from recent UK experience. Pharmacoeconomics 2006; 24:1055-68
6. Briggs A CK, Schulper M: Decision Modelling for Health Economic Evaluation, 2ndedition. Oxford, United Kingdom, Oxford University Press, 2007
7. Drummond MF: Methods for the Economic Evaluation of Health Care Programmes, 3rd edition. Oxford, United Kingdom, Oxford University Press, 2005
8. NICE: Guide to the methods of technology appraisal, National Institute for Clinical Excellence, 2004, pp 19-29
9. Bundgaard-Nielsen M, Secher NH, Kehlet H: 'Liberal' vs. 'restrictive' perioperative fluid therapy-a critical assessment of the evidence. Acta Anaesthesiol Scand 2009; 53:843-51
10. Bundgaard-Nielsen M, Ruhnau B, Secher NH, Kehlet H: Flow-related techniques for preoperative goal-directed fluid optimization. Br J Anaesth 2007; 98:38-44
11. Abbas SM, Hill AG: Systematic review of the literature for the use of oesophageal Doppler monitor for fluid replacement in major abdominal surgery. Anaesthesia 2008; 63:44-51
12. Kern JW, Shoemaker WC: Meta-analysis of hemodynamic optimization in high-risk patients. Crit Care Med 2002; 30: 1686-92
13. Poeze M, Greve JW, Ramsay G: Meta-analysis of hemody-namic optimization: Relationship to methodological quality. Crit Care 2005; 9:R771-9
14. Boyd O: Optimisation of oxygenation and tissue perfusion in surgical patients. Curr Anaesth Crit Care 2003; 13:206-14
15. Price JD, Sear JW, Venn RM: Perioperative fluid volume optimization following proximal femoral fracture. Cochrane Database Syst Rev 2004; CD003004
16. Sinclair S, James S, Singer M: Intraoperative intravascular volume optimisation and length of hospital stay after repair of proximal femoral fracture: Randomised controlled trial. Bmj 1997; 315:909-12
17. Venn R, Steele A, Richardson P, Poloniecki J, Grounds M, Newman P: Randomized controlled trial to investigate influence of the fluid challenge on duration of hospital stay and perioperative morbidity in patients with hip fractures. Br J Anaesth 2002; 88:65-71
18. Foss NB, Kehlet H: Mortality analysis in hip fracture patients: Implications for design of future outcome trials. Br J Anaesth 2005; 94:24-9
19. Shoemaker WC, Appel PL, Kram HB, Waxman K, Lee TS: Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest 1988; 94: 1176-86
20. EuroQol-a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990; 16:199-208
21. Hommel A, Ulander K, Bjorkelund KB, Norrman PO, Wing-strand H, Thorngren KG: Influence of optimised treatment of people with hip fracture on time to operation, length of hospital stay, reoperations and mortality within 1 year. Injury 2008; 39:1164-74
22. Burstrm K, Johannesson M, Diderichsen F: Swedish population health-related quality of life results using the EQ-5D. Qual Life Res 2001; 10:621-35
23. Burstrm K, Johannesson M, Diderichsen F: Health-related quality of life by disease and socio-economic group in the general population in Sweden. Health Policy 2001; 55:51-69
24. Tidermark J, Zethraeus N, Svensson O, Trnkvist H, Ponzer S: Femoral neck fractures in the elderly: Functional outcome and quality of life according to EuroQol. Qual Life Res 2002; 11:473-81
25. Gross CP, Anderson GF, Powe NR: The relation between funding by the National Institutes of Health and the burden of disease. N Engl J Med 1999; 340:1881-7
26. Michaud CM, Murray CJ, Bloom BR: Burden of disease-implications for future research. Jama 2001; 285:535-9
27. Townsend J, Buxton M: Cost effectiveness scenario analysis for a proposed trial of hormone replacement therapy. Health Policy 1997; 39:181-94
28. Davies L, Drummond M, Papanikolaou P: Prioritizing investments in health technology assessment. Can we assess potential value for money? Int J Technol Assess Health Care 2000; 16:73-91
29. Phelps CE, Parente ST: Priority setting in medical technology and medical practice assessment. Med Care 1990; 28:703-23
30. Boyd O, Hayes M: The oxygen trail: The goal. Br Med Bull 1999; 55:125-39
31. Rahbari NN, Zimmermann JB, Schmidt T, Koch M, Weigand MA, Weitz J: Meta-analysis of standard, restrictive and supplemental fluid administration in colorectal surgery. Br J Surg 2009; 96:331-41
32. Wilson J, Woods I, Fawcett J, Whall R, Dibb W, Morris C, McManus E: Reducing the risk of major elective surgery: Randomised controlled trial of preoperative optimisation of oxygen delivery. Bmj 1999; 318:1099-103
33. Takala J, Meier-Hellmann A, Eddleston J, Hulstaert P, Sramek V: Effect of dopexamine on outcome after major abdominal surgery: A prospective, randomized, controlled multicenter study. European Multicenter Study Group on Dopexamine in Major Abdominal Surgery. Crit Care Med 2000; 28:3417-23
34. Lobo SM, Salgado PF, Castillo VG, Borim AA, Polachini CA, Palchetti JC, Brienzi SL, de Oliveira GG: Effects of maximizing oxygen delivery on morbidity and mortality in high-risk surgical patients. Crit Care Med 2000; 28:3396-404
35. Gan TJ, Soppitt A, Maroof M, el-Moalem H, Robertson KM, Moretti E, Dwane P, Glass PS: Goal-directed intraoperative fluid administration reduces length of hospital stay after major surgery. ANESTHESIOLOGY 2002; 97:820-6
36. Conway DH, Mayall R, Abdul-Latif MS, Gilligan S, Tackaberry C: Randomised controlled trial investigating the influence of intravenous fluid titration using oesophageal Doppler monitoring during bowel surgery. Anaesthesia 2002; 57:845-9
37. Sandham JD, Hull RD, Brant RF, Knox L, Pineo GF, Doig CJ, Laporta DP, Viner S, Passerini L, Devitt H, Kirby A, Jacka M, Canadian Critical Care Clinical Trials Group: A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med 2003; 348:5-14
38. Pearse R, Dawson D, Fawcett J, Rhodes A, Grounds RM, Bennett ED: Early goal-directed therapy after major surgery reduces complications and duration of hospital stay. A randomised, controlled trial [ISRCTN38797445] Crit Care 2005; 9:R687-93
39. Noblett SE, Snowden CP, Shenton BK, Horgan AF: Randomized clinical trial assessing the effect of Doppler-optimized fluid management on outcome after elective colorectal resection. Br J Surg 2006; 93:1069-76
40. Donati A, Loggi S, Preiser JC, Orsetti G, Mnch C, Gabbanelli V, Pelaia P, Pietropaoli P: Goal-directed intraoperative therapy reduces morbidity and length of hospital stay in high-risk surgical patients. Chest 2007; 132:1817-24
41. Wakeling HG, McFall MR, Jenkins CS, Woods WG, Miles WF, Barclay GR, Fleming SC: Intraoperative oesophageal Doppler guided fluid management shortens postoperative hospital stay after major bowel surgery. Br J Anaesth 2005; 95: 634-42
42. Lobo SM, Lobo FR, Polachini CA, Patini DS, Yamamoto AE, de Oliveira NE, Serrano P, Sanches HS, Spegiorin MA, Queiroz MM, Christiano AC, Jr., Savieiro EF, Alvarez PA, Teixeira SP, Cunrath GS: Prospective, randomized trial comparing fluids and dobutamine optimization of oxygen delivery in high-risk surgical patients [ISRCTN42445141]. Crit Care 2006; 10:R72
43. Lopes MR, Oliveira MA, Pereira VO, Lemos IP, Auler JO, Jr., Michard F: Goal-directed fluid management based on pulse pressure variation monitoring during high-risk surgery: A pilot randomized controlled trial. Crit Care 2007; 11:R100
44. Senagore AJ, Emery T, Luchtefeld M, Kim D, Dujovny N, Hoedema R: Fluid management for laparoscopic colectomy: A prospective, randomized assessment of goal-directed administration of balanced salt solution or hetastarch coupled with an enhanced recovery program. Dis Colon Rectum 2009; 52:1935-40
45. Mayer J, Boldt J, Mengistu AM, Rohm KD, Suttner S: Goal-directed intraoperative therapy based on autocalibrated arterial pressure waveform analysis reduces hospital stay in high-risk surgical patients: A randomized, controlled trial. Crit Care 2010; 14:R18
46. Benes J, Chytra I, Altmann P, Hluchy M, Kasal E, Svitak R, Pradl R, Stepan M: Intraoperative fluid optimization using stroke volume variation in high risk surgical patients: Results of prospective randomized study. Crit Care 2010; 14:R118